Amir Ali, PharmD, BCOP

The significant surge in oncology drug shortages in 2023 particularly affected essential chemotherapeutic drugs.

Treatment options are distinct in their mechanisms, safety profiles, and implications for patients’ quality of life.

Ph-like ALL may be predominantly prevalent in Hispanic and Latino populations.

In crafting a patient-centered regimen, the convergence of expertise from physicians and pharmacists, paired with the values and preferences of patients, becomes paramount.

A single-center experience at a tertiary medical center precision medicine clinic provides insight.

Achieving MRD flow cytometry negativity is crucial in monitoring and predicting survival outcomes.

Substantial strides have been made in the management of Ph+ ALL.

The role of monoclonal antibodies in minimizing COVID-19–related complications remains important to assess.

A retrospective analysis presents unique results for AML treatment.